Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia: A Mini-Review

Inconsistent therapeutic responses have been observed among patients with sickle cell anemia (SCA) undergoing hydroxyurea (HU) following the adoption of the standardized protocol. Moreover, this treatment regimen necessitates a prolonged period to reach the maximum tolerated dose in which beneficial...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Santos Neres, Joelma Santana, Yahouédéhou, Sètondji Cocou Modeste Alexandre, Goncalves, Marilda Souza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301107/
https://www.ncbi.nlm.nih.gov/pubmed/37375804
http://dx.doi.org/10.3390/ph16060857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301107/
https://www.ncbi.nlm.nih.gov/pubmed/37375804
http://dx.doi.org/10.3390/ph16060857

Ejemplares similares